Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PEPD | P12955 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ACE | P12821 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5525138 | 1.00 | PEPD (0.48) | PEPDMEN1BLMKMT2AACE | |
| SCHEMBL4464323 | 1.00 | PEPD (0.48) | PEPDMEN1BLMKMT2AACE | |
| SCHEMBL34169 | 0.95 | PEPD (0.43) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL130870 | 0.95 | PEPD (0.43) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL598373 | 0.95 | PEPD (0.43) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL10578737 | 0.95 | PEPD (0.43) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL9663237 | 0.93 | PEPD (0.42) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL11660179 | 0.93 | PEPD (0.42) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL10739888 | 0.93 | PEPD (0.42) | PEPDMEN1BLMKMT2AALDH1A1 | |
| SCHEMBL7031195 | 0.93 | PEPD (0.42) | PEPDMEN1BLMKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114591501-A | Composite catalyst, carbon dioxide-based copolymer, and preparation method and application thereof | 上海华峰新材料研发科技有限公司 | 2022-06-07 | — | — | CN | claimed |
| US-20220119584-A1 | Degradable Urethane and Urethane-Urea Systems | LANXESS CORPORATION (US) | 2022-04-21 | — | — | US | claimed |
| CN-114369236-A | High-performance polyester ether polyol and preparation method and application thereof | 山东一诺威新材料有限公司 | 2022-04-19 | — | — | CN | claimed |
| CN-113337246-B | Photo-curing hot melt adhesive for difficult-to-adhere base material and preparation method thereof | 深圳市东升塑胶制品有限公司 | 2022-03-25 | — | — | CN | claimed |
| CN-113661222-A | Degradable urethane and urethane-urea systems | 朗盛公司 | 2021-11-16 | — | — | CN | claimed |
| CN-113637404-A | Anti-penetration curing waterproof agent for building wall and preparation method thereof | 孙建忠 | 2021-11-12 | — | — | CN | claimed |
| CN-110183576-B | Emulsifying agent for producing polybutadiene latex capable of being used for agglomeration, preparation method and application thereof | 万华化学(四川)有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-113337246-A | Photo-curing hot melt adhesive for difficult-to-adhere base material and preparation method thereof | 深圳市东升塑胶制品有限公司 | 2021-09-03 | — | — | CN | claimed |
| CN-112111056-A | High-activity bi-component catalytic system for preparing polyether polyol or polyether ester polyol and application thereof | 河北工业大学 | 2020-12-22 | — | — | CN | claimed |
| US-9080012-B2 | One-pot, neat ring opening polymerization to prepare resin | XEROX CORPORATION (US) | 2015-07-14 | — | — | US | claimed |
| US-8653048-B2 | Prodrugs based on gemcitabine structure and synthetic methods and applications thereof | SANLUGEN PHARMATECH LTD. (CN) | 2014-02-18 | — | — | US | claimed |
| EP-2267054-B1 | Polyester synthesis | XEROX CORP (US) | 2012-08-22 | — | — | EP | claimed |
| US-20120088908-A1 | Prodrugs Based on Gemcitabine Structure and Synthetic Methods and Applications Thereof | SANLUGEN PHARMATECH LTD. (CN) | 2012-04-12 | — | — | US | claimed |
| EP-2423215-A1 | PRODRUGS BASED ON GEMCITABINE STRUCTURE AS WELL AS SYNTHETIC METHOD AND APPLICATION THEREOF | Sanlugen Pharmatech Ltd. (CN) | 2012-02-29 | — | — | EP | claimed |
| US-20110123924-A1 | TONER COMPOSITIONS | XEROX CORPORATION (US) | 2011-05-26 | — | — | US | claimed |
| EP-2267054-A1 | Polyester synthesis | Xerox Corporation (US) | 2010-12-29 | — | — | EP | claimed |
| US-20100304287-A1 | POLYESTER SYNTHESIS | XEROX CORPORATION (US) | 2010-12-02 | — | — | US | claimed |
| US-20100055750-A1 | POLYESTER SYNTHESIS | XEROX CORPORATION (US) | 2010-03-04 | — | — | US | claimed |
| EP-0836627-B1 | POLYMER MATERIAL, PROCESS FOR ITS PRODUCTION AND USE THEREOF | PREFORM RAUMGLIEDERUNGSSYSTEME (DE) | 2001-10-17 | — | — | EP | claimed |
| US-4374954-A | Powder paint with epoxy and hydroxy copolymer and anhydride | FORD MOTOR COMPANY (US) | 1983-02-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088908-A1 | Prodrugs Based on Gemcitabine Structure and Synthetic Methods and Applications Thereof | TYMP, DCTD, GLS2 | PEPD 119/4885MEN1 2894/4885BLM 918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.